----- ----- -----


CATEGORY : Nutraceuticals

SUB CATEGORY : Capsule Hard Gelatin


STRENGTH : llagen Type II 300 mg,Glucosamin 100 mg,Silicic Acid 70 mg,L.lysine 25 mg,Vitamin C 30mg

FSSAI No. : 10116028000399

PHARMACOPOEIAL STATUS : llagen Type II 300 mg,Glucosamin 100 mg,Silicic Acid 70 mg,L.lysine 25 mg,Vitamin C 30mg



Displayed By :


Price : ₹0.00 /
1000 Available
Add To Cart

  • Brand Name (If already marketed)
    Mfg. Formula (Qualitative / Quantative) Avaliable
    Brief manufacturing process (Flow chart) Avaliable
    Manufacturing cycle time (Mfg lead time)
    Minimum & Maximum commercial batch size
    Annual capacity
    List of Equipment's Avaliable
    Process Validation Report for review (In case PV already completed) Avaliable
    Process controls (CPP) Avaliable
    Executed BMR and BPR for review Avaliable
    Stability data in final pack (Long Term/intermediate/Accelerated)
    B.Size of stability batches
    B.Size Scale-Up capacity
    In-vitro release profile : (If applicable) Avaliable
    Innovator or Competitor Brand name (Used as reference) Avaliable
    Media-1 (Text Entry Field) Avaliable
    Media-2 (Text Entry Field) Avaliable
    Media-3 (Text Entry Field) Avaliable
    BE / CT study  report (If applicable) Avaliable
    Scale Up and Process Validation report Avaliable
    MSDS Avaliable
    Shelf life of the product in company letterhead Avaliable
  • Vendor details for Active Ingredients Avaliable
    Pharmacopoeial status
    Specification (s) Avaliable
    Valid Reference standard/Working standard availability with CoA Avaliable
    Valid Impurity standard availability with CoA Avaliable
    Critical Quality Attribute (If any) Avaliable
    Excipient vendor details Avaliable
    Quality control Requirement Details Avaliable
    Active Ingredients Specification Avaliable
    Excipients Specification Avaliable
    In-process / Bulk Specification Avaliable
    Finished Product Specification Avaliable
    Shelf Life Specification Avaliable
    Active Ingredients Method Of Analysis Avaliable
    Excipients Method Of Analysis Avaliable
    In-process / Bulk Method Of Analysis Avaliable
    Finished Product Method Of Analysis Avaliable
    Shelf Life Method Of Analysis Avaliable
    Three batch samples (Acc/Near Exp/Fresh)in final pack (Equivalent of two times of complete analysis) Avaliable
    If Partner / Customer want to do joint analysis, will you provide suitable dates? Avaliable
  • Blend / Bulk Assay Method Avaliable
    FP / Stability Assay Method Avaliable
    Related Substances (Impurities) Avaliable
    Uniformity Of Dosage Units Avaliable
    Dissolution Avaliable
    Res Solv (OVI) Avaliable
    Preservative content Avaliable
    Heavy metals Avaliable
    Identification Test Avaliable
    Others (If any) Avaliable
  • Manufacturing license with validity Avaliable
    Manufacturing license number Avaliable
    Location license (form 25, form 28 In case of India) Avaliable
    Stability Data Avaliable
    Long Term Stability Data
    Accelerated Stability Data
  • If Partner / Customer want to do Quality and Facility audit, will you provide suitable dates? Avaliable
    Launch period of the product (Lead Time)
  • Generic Name Avaliable
    Dosage form Avaliable
    Label Claim (With special ingredients if added in the formulation) Avaliable
    Colours Avaliable
    Details of pack- Pack size and Type of pack Avaliable
    Warning as per DCGI Avaliable
    Directions for use if any Avaliable
    Storage condition and shelf life Avaliable
    Special warning if any Avaliable
    Packing material: Layouts, mock-ups (Sales and PS), leaflet in editable form. Avaliable
    Mfg. Address Avaliable
    Any other Text Matter for printing Avaliable
    List of approved vendors Avaliable

Subscribe to get the latest Pharma Trends

We are sure, we dont spam with bulk emails and your email address is safe and will not be shared with any third parties.